Unknown

Dataset Information

0

A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.

ABSTRACT: The presence of recurrent high-risk mutations in cyclin-dependent kinase inhibitor 2A/cyclin-dependent kinase 4 (CDKN2A/CDK4) among melanoma-prone families suggests that a high-throughput, multiplex assay could serve as an effective initial screening tool. To this end, we have developed a multiplex bead-based assay for high-throughput CDKN2A/CDK4 genotyping in the context of familial melanoma. Genomic DNA from 1,603 subjects (1,005 in training set and 598 in validation set) were amplified by multiplex PCR using five CDKN2A/CDK4 primer sets followed by multiplex allele-specific primer extension for 39 distinct germline variants. The products were then sorted and analyzed using the Luminex xMAP system. Genotypes were compared with previously determined sequence data. In the Toronto training cohort, all 145 samples with known variants were detected by the bead assay (100% concordance). Analysis of the 598 samples from the GenoMEL validation set led to identification of 150/155 expected variants (96.77%). Overall, the bead assay correctly genotyped 1,540/1,603 (96.07%) of all individuals in the study and 1,540/1,545 (99.68%) of individuals whose variants were represented in the probe set. Out of a total of 62,517 allelic calls, 62,512 (99.99%) were correctly assigned. The multiplex bead-based assay is an accurate method for genotyping CDKN2A/CDK4 variants and is potentially useful in genotyping low-to-moderate melanoma risk single-nucleotide polymorphisms.

SUBMITTER: Lang JM 

PROVIDER: S-EPMC3045700 | biostudies-literature | 2011 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The presence of recurrent high-risk mutations in cyclin-dependent kinase inhibitor 2A/cyclin-dependent kinase 4 (CDKN2A/CDK4) among melanoma-prone families suggests that a high-throughput, multiplex assay could serve as an effective initial screening tool. To this end, we have developed a multiplex bead-based assay for high-throughput CDKN2A/CDK4 genotyping in the context of familial melanoma. Genomic DNA from 1,603 subjects (1,005 in training set and 598 in validation set) were amplified by mul  ...[more]

Similar Datasets

Unknown Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families.
| S-EPMC6926144 | biostudies-literature
Unknown Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
| S-EPMC7505133 | biostudies-literature
Unknown CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
| S-EPMC2375081 | biostudies-other
Unknown 3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.
| S-EPMC8193344 | biostudies-literature
Unknown Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.
| S-EPMC3244023 | biostudies-literature
Unknown Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
| S-EPMC3607098 | biostudies-literature
Unknown The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of <i>CDKN2A</i> and <i>CDK4</i>.
| S-EPMC8049096 | biostudies-literature
Unknown Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
| S-EPMC2598064 | biostudies-literature
Unknown Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.
| S-EPMC2361801 | biostudies-literature
Unknown Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.
| S-EPMC6916246 | biostudies-literature